Liver Human Emulation System

Closed Special Notice Posted

Solicitation number
FDA_SS_1250159
Agency
FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
Responses due
Set-aside
Total Small Business

Opportunity facts

NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Place of performance
Laurel, Maryland 20708, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Food and Drug Administration published a Special Notice announcing its intent to issue a sole source purchase order for a Liver Human Emulation System to Emulate. The notice seeks a Liver-Chip, Quad-Culture Kits, Zoe Culture Modules, an Orb Hub Module and associated equipment with a simple user interface and small footprint to further the agency's regulatory science initiatives.

The purpose of the notice is to procure a Liver Human Emulation System to support the FDA's regulatory review processes. Responses from interested parties are due by December 23, 2021 to demonstrate capability to meet the requirements, with the agency intending to award to Emulate within 10 days thereafter unless another party proves ability to provide the necessary products and services. Only small businesses are eligible under the total set-aside designation. The liver emulation system sought comprises various components for replicating human liver functions in vitro to advance non-animal testing approaches.

Notice text

The purpose of this notice is to inform the public that the FDA anticipates
issuing a sole source purchase order to procure a Liver Human Emulation System.

Attachments

Files attached to this notice, newest first
File Type Posted
Notice of Intent to SS _1250159.pdf PDF

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity